Healthcare technology company signs SRAs with NHS Trusts - Digital Health Age

Healthcare technology company Sensyne Health has signed Strategic Research Agreements (SRA) with Wye Valley and George Eliot Hospital NHS Trusts. The agreements will allow Sensyne Health to analyse anonymised patient data using clinical artificial intelligence (Clinical AI) technology. The purpose of the research is to derive new insights that will improve the care of NHS Trusts' patients and help to find new treatments. Both Trusts will receive a £2.5 million equity stake in Sensyne Health (at a price of £1.75 per share) and will also benefit from royalties that arise from any discoveries. The royalties the Trust receives will be reinvested back into the NHS which can fund further research and can help deliver higher quality patient care at lower cost.